[1] Barzilai O, Laufer I, Yamada Y, et al.Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease[J]. J Clin Oncol, 2017, 35(21): 2419-2427.
[2] Barzilai O, Mclaughlin L, Amato M, et al.Predictors of quality of life improvement after surgery for metastatic tumors of the spine: prospective cohort study[J]. Spine J, 2018,18(7): 1109-1115.
[3] Lee BH, Park JO, Kim HS, et al.Perioperative complication and surgical outcome in patients with spine metastases: retrospective 200-case series in a single institute[J]. Clin Neurol Neurosurg. 2014, 122(13): 80-86.
[4] Sciubba DM, Pennington Z, Colman MW, et al.Spinal metastases 2021: a review of the current state of the art and future directions[J]. Spine J, 2021, 21(9): 1414-1429.
[5] D’Oronzo, Stucci S, Tucci M, et al. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications[J]. Cancer Treat Rev, 2015, 41(9): 798-808.
[6] Fornetti J, Welm AL, Stewart SA.Understanding the bone in cancer metastasis[J]. J Bone Miner Res, 2018, 33(12): 2099-2113.
[7] Baxter NN, Habermann EB, Tepper JE, et al.Risk of pelvic fractures in older women following pelvic irradiation[J]. JAMA, 2005, 294(20): 2587-2593.
[8] Elliott SP, Jarosek SL, Alanee SR, et al.Three‐dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture[J]. Cancer, 2011, 117(19): 4557-4565.
[9] Itagaki MW, Talenfeld AD, Kwan SW, et al.Percutaneous vertebroplasty and kyphoplasty for pathologic vertebral fractures in the Medicare population: safer and less expensive than open surgery[J]. J Vasc Interv Radiol, 2012, 23(11): 1423-1429.
[10] 中华医学会骨科学分会骨肿瘤学组.脊柱转移瘤外科治疗指南[J]. 中华骨科杂志,2019,39(12):717-726.
[11] Luchini C, Stubbs B, Solmi M, et al.Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale[J]. World J Meta-Anal, 2017, 5(4): 80-84.
[12] Higgins JPT, Green S.Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (Updated March 2011)[M]. London: Cochrane Collaboration, 2011: 15-16.
[13] Huang M, Zhu H, Liu TG, et al.Comparison of external radiotherapy and percutaneous vertebroplasty for spinal metastasis[J]. Asia Pac J Clin Oncol, 2016, 12(2): e201-e208.
[14] 黄引芳,傅深,吴春根.骨水泥成形辅以放射治疗应用于恶性肿瘤骨转移癌:可为临床首选方案?[J]. 中国组织工程研究与临床康复,2010,14(8):1483-1487.
[15] 姚维,郭良玉,李丙男,等.经皮椎体成形术联合放疗治疗椎体转移癌的疼痛及生活质量分析[J]. 癌症进展,2019,17(5):599-602.
[16] 成宪江,邵月娟,王昆.椎体成形术联合放疗减轻骨转移癌疼痛的疗效观察[J]. 中国肿瘤临床,2016,43(9):371-375.
[17] 曹叙勇. 椎体成形术联合术后放疗与单纯放疗治疗脊柱转移瘤的疗效比较及生存预后分析[D]. 合肥:安徽医科大学, 2018.
[18] 孙建业,伦俊杰,胡效坤,等.椎体成形术联合调强放射治疗脊柱转移瘤疗效[J]. 中国介入影像与治学,2019,16(11): 676-681.
[19] 胡鸿,何学红,游箭,等.经皮椎体成形术联合放射治疗椎体转移瘤[J]. 中国介入影像与治疗学,2014,11(6):341-344.
[20] 邢文阁,郭志,王军,等.椎体转移瘤椎体成形术与放射治疗的临床研究[J]. 中华医学杂志,2010,90(11):743-747.
[21] 许建伟,张海兵,郑少俊,等.经皮椎体成形术联合放疗治疗椎体转移瘤临床观察[J]. 浙江中西医结合杂志,2013,23(12):998-1001.
[22] 白佳佳. 放疗联合椎体成形术治疗椎体转移瘤疼痛的临床观察[J]. 今日健康,2016,15(3):133-133.
[23] 杨怡,刘佰易.经皮椎体成形术联合放疗治疗椎体转移癌的临床疗效研究[J]. 现代医药卫生,2019,35(17):2608-261.
[24] 陆军,邓敬兰,赵海涛,等.脊柱转移瘤放疗联合椎体成形术治疗的前瞻性研究[J]. 中华放射肿瘤学杂志,2005,14(1): 46-50.
[25] Laufer I, Rubin DG, Lis E, et al.The NOMS framework: approach to the treatment of spinal metastatic tumors[J]. Oncologist, 2013, 18(6): 744-751.
[26] Tokuhashi Y, Uei H, Oshima M, et al.Scoring system for prediction of metastatic spine tumor prognosis[J]. World J Orthop, 2014, 5(3): 262-271.
[27] Bollen L, Wibmer C, van der Linden YM, et al. Predictive value of six prognostic scoring systems for spinal bone metastases: an analysis based on 1379 patients[J]. Spine, 2016, 41(3): E155-E162.
[28] Wibmer C, Leithner A, Hofmann G, et al.Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems[J]. Spine, 2011, 36(23): 1977-1986.
[29] Lundin B, Björkholm E, Lundell M, et al.Insufficiency fractures of the sacrum after radiotherapy for gynaecological malignancy[J]. Acta Oncol, 1990, 29(2): 211-215.
[30] Oh D, Huh SJ.Insufficiency fracture after radiation therapy[J]. Radiat Oncol J, 2014, 32(4): 213-220.
[31] Matcuk GR, Mahanty SR, Skalski MR, et al.Stress fractures: pathophysiology, clinical presentation, imaging features, and treatment options[J]. Emerg Radiol, 2016, 23(4): 365-375.
[32] Higham E, Faithfull S.Bone health and pelvic radiotherapy[J]. Clin Oncol, 2015, 27(11): 668-678.
[33] Cao X, Wu X W, Frassica D, et al.Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells[J]. Proc Natl Acad Sci USA, 2011, 108(4): 1609-1614.
[34] 刘璇,陆祖宏.骨代谢调控的垂体-骨轴机制[J]. 中华内分泌代谢杂志,2011,27(2):184-188.
[35] Marcucci G, Beltrami G, Tamburini A, et al.Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors[J]. Ann Oncol, 2019, 30(6): 908-920.
[36] Sun L, Peng Y Z, Sharrow A C, et al.FSH Directly Regulates Bone Mass[J]. Cell, 2006, 125(2): 247-260.
[37] Ethun CG, Bilen M A, Jani AB, et al.Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology[J]. CA Cancer J Clin, 2017, 67(5): 362-377.
[38] Quraishi NA, Arealis G, Salem KMI, et al.The surgical management of metastatic spinal tumors based on an epidural spinal cord compression (ESCC) scale. Spine[J]. 2015;15:1738-1743.
[39] van der Velden JM, Versteeg AL, Verkooijen HM, et al. Prospective evaluation of the relationship between mechanical stability and response to palliative radiotherapy for symptomatic spinal metastases[J]. Oncologist, 2017, 22(8): 972-978.
[40] Berenson J, Pflugmacher R, Jarzem P, et al.Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial[J]. Lancet Oncol, 2011, 12(3): 225-235.
[41] Balestrino A, Boriani S, Cecchinato R, et al.Vertebroplasty shows no antitumoral effect on vertebral metastasis: a case-based study on anatomopathological examinations[J]. Eur Spine J, 2020, 29(12): 3157-3162.
[42] 陈珑. 经皮椎体成形术注射骨水泥对椎柱肿瘤细胞毒作用的临床和实验研究 [D]. 上海:第二军医大学,2010.
[43] 李春龙. PMMA骨水泥在不同粘稠状态下抗肿瘤作用的动物实验研究 [D]. 苏州:苏州大学,2011.
[44] 常永闯. 经皮椎体成形术中两种不同类型骨水泥抗肿瘤作用的动物实验研究 [D]. 苏州:苏州大学,2010.
[45] De Meerleer G, Khoo V, Escudier B, et al.Radiotherapy for renal-cell carcinoma[J]. Lancet Oncol, 2014, 15(4): e170-e177.
[46] Laufer I. Rubin DG. Lis E, et al.The NOMS framework:approach to the treatment of spinal metastatic tumors[J].Oncologist, 2013, 18(6): 744-751.
[47] Amini A, Altoos B, Bourlon MT, et al.Local control rales of melastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?[J]. Pract Radial Oncol, 2015, 5(6): e589-e596.
[48] He L, Liu Y, Han H, et al.Survival outcomes after adding stereotactic body radiotherapy to metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors[J]. Am J Clin Oncol, 2020, 43(1): 58-63.
[49] Wang CJ, Christie A. Lin MH, et al.Safety and efficacy of stereotactie ablative radiation therapy for renal cell carcinoma extracranial metastases[J]. Int J Radiat Oncol Biol Phys, 2017, 98(1): 91-100.
[50] Sahgal A. Whyne CM, Ma L, et al.Vertebral compipssion fracture after slereotactie body radiotherapy for spinal netastases[J].Lancet Oneol, 2013, 14(8): e310-e320.
[51] Thibault l, Atenafu EC, Chang E, et al. Risk of vertebral compression fracture specifie to osteolytie renal cell carcinoma–pinal melasases after stereotaelie body radiotherapy: a multi-inslitutional stud[J]. J Radio-urg SBRT, 2015, 3(4): 297-305.